STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • February 5th, 2014 • Sacks Michael Ivan • Pharmaceutical preparations • New York
THIS STOCKHOLDERS’ AGREEMENT is made as of the 31st day of January, 2014 by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT”) and IPMD GmbH, an Austrian limited liability company (“IPMD” and, collectively, with Sacks and TPT, the “Investors”).
EQUALIZATION AGREEMENTEqualization Agreement • February 5th, 2014 • Sacks Michael Ivan • Pharmaceutical preparations • New York
THIS EQUALIZATION AGREEMENT (this “Agreement”) is made as of the 31st day of January, 2014 by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT” and, together with Sacks, the “Investors”), Melmed Holdings AG, a company incorporated in Switzerland (“Melmed”), and IPMD GmbH, an Austrian limited liability company (“IPMD”). The Investors, Melmed and IPMD are referred to collectively in this Agreement as the “parties.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 5th, 2014 • Sacks Michael Ivan • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of the 31st day of January, 2014, by and among ULURU Inc., a Nevada corporation (the “Company”), Michael Sacks (“Sacks”) and The Punch Trust (“TPT,” and together with Sacks and any party added to this Agreement pursuant to Section 3.13, the “Investors”).
IMPLEMENTATION AGREEMENTImplementation Agreement • February 5th, 2014 • Sacks Michael Ivan • Pharmaceutical preparations • New York
This Implementation Agreement (this “Agreement”) is made as of January 31, 2014 (the “Effective Date”) by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT,” and together with Sacks, the “Holders”), IPMD GmbH, an Austrian limited liability company (the “Assignor”), and ULURU Inc., a Nevada corporation (the “Company”). The Company, the Assignor and the Holders are referred to collectively in this agreement as the “parties.”
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • March 2nd, 2017 • Sacks Michael Ivan • Pharmaceutical preparations • New York
THIS INVESTOR RIGHTS AGREEMENT (this “Agreement”), is made as of the 27th day of February, 2017, by and among ULURU Inc., a Nevada corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
FIRST AMENDMENT TO VOTING AGREEMENTVoting Agreement • April 13th, 2017 • Sacks Michael Ivan • Pharmaceutical preparations • New York
THIS FIRST AMENDMENT TO VOTING AGREEMENT (this “First Amendment”), is made and entered into as of this 31st day of March, 2017, by and among ULURU, Inc., a Nevada corporation (the “Company”), each holder of the Company’s Series B Convertible Preferred Stock, $0.001 par value per share listed on Schedule A to the Voting Agreement (together with any subsequent transferees, who become parties to the Voting Agreement as “Investors” pursuant to Subsection 5.1 of the Voting Agreement, the “Investors”), and those certain stockholders of the Company listed on Schedule B to the Voting Agreement (the “Key Holders,” and together collectively with the Investors, the “Stockholders”). Capitalized terms used herein shall have the meaning given such terms in the Voting Agreement.
ULURU INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • April 4th, 2016 • Sacks Michael Ivan • Pharmaceutical preparations • Nevada
THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is made and entered into as March 29, 2016 by and between ULURU Inc., a Nevada corporation (the “Company”), and the investors who have executed a counterpart signature page to this Agreement (each, “Investor”; collectively, the “Investors”). For convenience, the Investors are identified on Exhibit A.
Put and call AgreementPut and Call Agreement • July 29th, 2015 • Sacks Michael Ivan • Pharmaceutical preparations • New York
THIS put and call Agreement (this “Agreement”) is made and entered into as of July 29, 2015 by and between Michael I. Sacks (“Sacks”) and Centric Capital Ventures LLC, a Delaware limited liability company (“Centric”).
Michael SacksSacks Michael Ivan • February 5th, 2014 • Pharmaceutical preparations
BACKSTOP AGREEMENTBackstop Agreement • March 2nd, 2017 • Sacks Michael Ivan • Pharmaceutical preparations • New York
This BACKSTOP AGREEMENT (this “Agreement”) is entered into as of February 27, 2017 (the “Effective Date”) by and between ULURU INC., a Nevada corporation (the “Company”), Bradley J. Sacks (“Buyer”) and Velocitas Partners LLC (“Velocitas”).
VOTING AGREEMENTAdoption Agreement • March 2nd, 2017 • Sacks Michael Ivan • Pharmaceutical preparations • New York
THIS VOTING AGREEMENT (this “Agreement”), is made and entered into as of this 27th day of February, 2017, by and among ULURU, Inc., a Nevada corporation (the “Company”), each holder of the Company’s Series B Convertible Preferred Stock, $0.001 par value per share (the “Series B Preferred Stock”) listed on Schedule A (together with any subsequent transferees, who become parties hereto as “Investors” pursuant to Subsection 5.1, the “Investors”), and those certain stockholders of the Company listed on Schedule B (the “Key Holders,” and together collectively with the Investors, the “Stockholders”).
